Deep TMS News & Events - Stay Updated with BrainsWay

News & Events

November 25, 2025

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

, November 21, 2025

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

Deep TMS™ becomes first and only TMS device cleared in treatment of patients ages 15 to 86 suffering...

November 20, 2025

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

Multicenter, randomized, controlled study will evaluate Company’s next-generation multichannel TMS...

, November 21, 2025

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

Deep TMS™ becomes first and only TMS device cleared in treatment of patients ages 15 to 86 suffering...

June 12 - June 14, 2025

Clinical TMS Society (CTMSS)

BrainsWay is attending the CTMSS conference June 13th through June 14th, in San Diego, CA. We invite...

May 9 - May 14, 2025

17th World Congress of International Neuromodulation Society

BrainsWay is attending the International Neuromodulation Society conference from May 9th through May...

In the Media

November 24, 2025

FDA grants 510(k) clearance for TMS as adjunctive for major depressive disorder in young people

Key takeaways: BrainsWay Deep TMS is cleared for use by adolescents and adults with major depressive...

October 1, 2025

Serenity Mental Health Centers Adopting SWIFT Deep TMS

Serenity Mental Health Centers, one of the leading providers of Deep TMS treatment nationwide, commits...

September 26, 2025

Coordinated transcranial magnetic stimulation, ketamine may benefit refractory depression

Coordinating transcranial magnetic stimulation (TMS) with ketamine therapy shows promising potential...